BIOMAT Database Logo BIOMAT Database Logo

T cell infiltrate predicts long-term survival following resection of colorectal cancer liver metastases. 2009

Steven C Katz, and Venu Pillarisetty, and Zubin M Bamboat, and Jinru Shia, and Cyrus Hedvat, and Mithat Gonen, and William Jarnagin, and Yuman Fong, and Leslie Blumgart, and Michael D'Angelica, and Ronald P DeMatteo
Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

BACKGROUND While tumor infiltrating lymphocytes (TIL) have been shown to independently predict survival in primary colorectal cancer, the prognostic implications of TIL in resectable colorectal cancer liver metastases (CRCLM) have not been previously defined. This study examines the correlation between TIL numbers and survival following hepatic resection. METHODS We studied patients who survived <or=2 or >or=10 years following CRCLM resection. Immunohistochemistry was performed on tissue microarrays (TMAs) to determine the number of T cells within CRCLM. Correlation between TIL frequency and <or=2 or >or=10 year survival was determined while controlling for established prognostic factors. RESULTS Of 162 patients, 104 survived <or=2 years and 58 survived >or=10 years. Independent correlates of 10-year survival following CRCLM resection included a high number of CD8 T cells, a low number of CD4 T cells, and a clinical risk score of <or=2 (P < 0.001). Among 10-year survivors, 31% of patients had a high number of CD8 T cells compared with 8% for <or=2 year survivors (P < 0.01). Surprisingly, only 22% of 10-year survivors had a high number of CD4 T cells, in contrast to 69% of those who died within 2 years (P < 0.001). The combination of CD8 and CD4 T cell counts was a more powerful predictor of survival than either marker alone. CONCLUSIONS CRCLM T cell number is an independent correlate of long-term survival following liver resection. We conclude that CRCLM TIL analysis represents a potentially powerful prognostic tool which will require further validation prior to broad application.

UI MeSH Term Description Entries
D007124 Immunoenzyme Techniques Immunologic techniques based on the use of: (1) enzyme-antibody conjugates; (2) enzyme-antigen conjugates; (3) antienzyme antibody followed by its homologous enzyme; or (4) enzyme-antienzyme complexes. These are used histologically for visualizing or labeling tissue specimens. Antibody Enzyme Technique, Unlabeled,Enzyme Immunoassay,Enzyme-Labeled Antibody Technique,Immunoassay, Enzyme,Immunoperoxidase Techniques,Peroxidase-Antiperoxidase Complex Technique,Peroxidase-Labeled Antibody Technique,Antibody Enzyme Technic, Unlabeled,Enzyme-Labeled Antibody Technic,Immunoenzyme Technics,Immunoperoxidase Technics,Peroxidase-Antiperoxidase Complex Technic,Peroxidase-Labeled Antibody Technic,Antibody Technic, Enzyme-Labeled,Antibody Technic, Peroxidase-Labeled,Antibody Technics, Enzyme-Labeled,Antibody Technics, Peroxidase-Labeled,Antibody Technique, Enzyme-Labeled,Antibody Technique, Peroxidase-Labeled,Antibody Techniques, Enzyme-Labeled,Antibody Techniques, Peroxidase-Labeled,Enzyme Immunoassays,Enzyme Labeled Antibody Technic,Enzyme Labeled Antibody Technique,Enzyme-Labeled Antibody Technics,Enzyme-Labeled Antibody Techniques,Immunoassays, Enzyme,Immunoenzyme Technic,Immunoenzyme Technique,Immunoperoxidase Technic,Immunoperoxidase Technique,Peroxidase Antiperoxidase Complex Technic,Peroxidase Antiperoxidase Complex Technique,Peroxidase Labeled Antibody Technic,Peroxidase Labeled Antibody Technique,Peroxidase-Antiperoxidase Complex Technics,Peroxidase-Antiperoxidase Complex Techniques,Peroxidase-Labeled Antibody Technics,Peroxidase-Labeled Antibody Techniques,Technic, Enzyme-Labeled Antibody,Technic, Immunoenzyme,Technic, Immunoperoxidase,Technic, Peroxidase-Antiperoxidase Complex,Technic, Peroxidase-Labeled Antibody,Technics, Enzyme-Labeled Antibody,Technics, Immunoenzyme,Technics, Immunoperoxidase,Technics, Peroxidase-Antiperoxidase Complex,Technics, Peroxidase-Labeled Antibody,Technique, Enzyme-Labeled Antibody,Technique, Immunoenzyme,Technique, Immunoperoxidase,Technique, Peroxidase-Antiperoxidase Complex,Technique, Peroxidase-Labeled Antibody,Techniques, Enzyme-Labeled Antibody,Techniques, Immunoenzyme,Techniques, Immunoperoxidase,Techniques, Peroxidase-Antiperoxidase Complex,Techniques, Peroxidase-Labeled Antibody
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Steven C Katz, and Venu Pillarisetty, and Zubin M Bamboat, and Jinru Shia, and Cyrus Hedvat, and Mithat Gonen, and William Jarnagin, and Yuman Fong, and Leslie Blumgart, and Michael D'Angelica, and Ronald P DeMatteo
Long-term survival following delayed presentation and resection of colorectal liver metastases.
September 2011, The British journal of surgery,
Steven C Katz, and Venu Pillarisetty, and Zubin M Bamboat, and Jinru Shia, and Cyrus Hedvat, and Mithat Gonen, and William Jarnagin, and Yuman Fong, and Leslie Blumgart, and Michael D'Angelica, and Ronald P DeMatteo
Trends in long-term survival following liver resection for hepatic colorectal metastases.
June 2002, Annals of surgery,
Steven C Katz, and Venu Pillarisetty, and Zubin M Bamboat, and Jinru Shia, and Cyrus Hedvat, and Mithat Gonen, and William Jarnagin, and Yuman Fong, and Leslie Blumgart, and Michael D'Angelica, and Ronald P DeMatteo
Long-term survival following liver resection for colorectal metastases--an Adelaide experience.
September 2004, Annals of the Academy of Medicine, Singapore,
Steven C Katz, and Venu Pillarisetty, and Zubin M Bamboat, and Jinru Shia, and Cyrus Hedvat, and Mithat Gonen, and William Jarnagin, and Yuman Fong, and Leslie Blumgart, and Michael D'Angelica, and Ronald P DeMatteo
Tumour inflammatory infiltrate predicts survival following curative resection for node-negative colorectal cancer.
August 2009, European journal of cancer (Oxford, England : 1990),
Steven C Katz, and Venu Pillarisetty, and Zubin M Bamboat, and Jinru Shia, and Cyrus Hedvat, and Mithat Gonen, and William Jarnagin, and Yuman Fong, and Leslie Blumgart, and Michael D'Angelica, and Ronald P DeMatteo
Influence of postoperative morbidity on long-term survival following liver resection for colorectal metastases.
September 2003, The British journal of surgery,
Steven C Katz, and Venu Pillarisetty, and Zubin M Bamboat, and Jinru Shia, and Cyrus Hedvat, and Mithat Gonen, and William Jarnagin, and Yuman Fong, and Leslie Blumgart, and Michael D'Angelica, and Ronald P DeMatteo
Perioperative morbidity affects long-term survival in patients following liver resection for colorectal metastases.
June 2008, Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract,
Steven C Katz, and Venu Pillarisetty, and Zubin M Bamboat, and Jinru Shia, and Cyrus Hedvat, and Mithat Gonen, and William Jarnagin, and Yuman Fong, and Leslie Blumgart, and Michael D'Angelica, and Ronald P DeMatteo
Long-term survival and cure model following liver resection for breast cancer metastases.
July 2018, Breast cancer research and treatment,
Steven C Katz, and Venu Pillarisetty, and Zubin M Bamboat, and Jinru Shia, and Cyrus Hedvat, and Mithat Gonen, and William Jarnagin, and Yuman Fong, and Leslie Blumgart, and Michael D'Angelica, and Ronald P DeMatteo
Preoperative peripheral blood neutrophil count predicts long-term outcomes following hepatic resection for colorectal liver metastases.
May 2017, Oncology letters,
Steven C Katz, and Venu Pillarisetty, and Zubin M Bamboat, and Jinru Shia, and Cyrus Hedvat, and Mithat Gonen, and William Jarnagin, and Yuman Fong, and Leslie Blumgart, and Michael D'Angelica, and Ronald P DeMatteo
Long-term outcome in patients with adrenal metastases following resection of colorectal liver metastases.
August 2009, The British journal of surgery,
Steven C Katz, and Venu Pillarisetty, and Zubin M Bamboat, and Jinru Shia, and Cyrus Hedvat, and Mithat Gonen, and William Jarnagin, and Yuman Fong, and Leslie Blumgart, and Michael D'Angelica, and Ronald P DeMatteo
The effect of the enhanced recovery programme on long-term survival following liver resection for colorectal liver metastases.
June 2023, Langenbeck's archives of surgery,
Copied contents to your clipboard!